Harnessing Microbial Effectors for Macrophage-Mediated Drug Delivery
Main Authors: | Anton Du Preez Van Staden, Johan G. Visser, Yigael S. L. Powrie, Carine Smith |
---|---|
Format: | Article |
Language: | English |
Published: |
American Chemical Society
2024-04-01
|
Series: | ACS Omega |
Online Access: | https://doi.org/10.1021/acsomega.3c10519 |
Similar Items
-
Harnessing Macrophages for Controlled-Release Drug Delivery: Lessons From Microbes
by: Johan Georg Visser, et al.
Published: (2019-01-01) -
Unresolved intramuscular inflammation, not diminished skeletal muscle regenerative capacity, is at the root of rheumatoid cachexia: insights from a rat CIA model
by: Tracey Ollewagen, et al.
Published: (2021-11-01) -
Zebrafish behavioral response to ivermectin: insights into potential neurological risk
by: Yigael Powrie, et al.
Published: (2022-12-01) -
Recent Advances in Macrophage-Mediated Drug Delivery Systems
by: Liang T, et al.
Published: (2021-04-01) -
Harnessing Extracellular Matrix Biology for Tumor Drug Delivery
by: Nithya Subrahmanyam, et al.
Published: (2021-01-01)